Yi Chen

Avi Dahan

Shagun Singh

Shagun Singh Chadha

- Zynex, Inc. is changing its strategy for the NiCO™ CO-Oximeter, developed by its subsidiary Zynex Monitoring Solutions, Inc. (ZMS), and will now seek a commercialization partner rather than pursuing independent commercialization.  **[846475_0001104659-25-097588_zyxi-20251001x8k.htm:1]** 
- This strategic shift resulted in the **termination of a majority of ZMS employees** on **October 1, 2025**.  **[846475_0001104659-25-097588_zyxi-20251001x8k.htm:1]** 
- The company expects to incur approximately **$0.1 million** in pre-tax cash severance charges in **Q4 2025** and up to approximately **$31.0 million** in pre-tax non-cash asset impairment charges, primarily related to ZMS goodwill and assets, in **Q3 2025**.  **[846475_0001104659-25-097588_zyxi-20251001x8k.htm:1]**

ZYNEX (ZYXI)